Inclusion Criteria:  BMI between 18 and 30 kg/m², inclusive. Body weight ≥50 kg Voluntary written informed consent Good general health with no clinically significant and/or relevant abnormalities of medical history or prior to dosing evaluations, including physical examination, vital signs and ECG and screening clinical laboratory results  Exclusion Criteria:  Current or recurrent disease that could affect the study conduct or laboratory assessments History of current or relevant previous non-self-limiting gastrointestinal disorders Currently suffering from disease known to impact gastric emptying, e.g., migraine, Type 1 or Type 2 diabetes mellitus Untreated hypertension or has hypertension under treatment. Diagnosis of an immunosuppressive illness or a condition requiring chronic immunosuppression. As a result of a physical examination or screening investigations, and available prior to dosing evaluations, the PMI or medically qualified designee/physician responsible considers the volunteer unfit for the study Any contradictions to the gamma scintigraphy procedure Measured body temperature >38°C at screening visit (COVID-19 risk reduction procedure)